This site is intended for Healthcare professionals only.

USFDA approves Tetraphase Pharma’s antibiotic


USFDA approves Tetraphase Pharma’s antibiotic

The U. S. Food and Drug Administration approved Tetraphase Pharmaceuticals Inc’s antibiotic for complicated intra-abdominal infections, providing a new option to combat the growing problem of treatment-resistant bacteria.

The approval allows the use of the drug, Xerava, in patients aged 18 and older.

The company said it expects to launch the drug in the United States in the fourth quarter.

(Reporting by Saumya Sibi Joseph and Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila)



Source: REUTERS
0 comment(s) on USFDA approves Tetraphase Pharma’s antibiotic

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted